32 Comments
User's avatar
PRATHAM GUPTA's avatar

Amazing ROTI💯, fun way of educating helps us understand better. Thanks sir 🙌🏼

Expand full comment
Gokulnath Panneerselvam's avatar

Bajaj is real CDMO or not ji..

Expand full comment
Sajal Kapoor's avatar

Bajaj Electricals is FMEG

Expand full comment
Gokulnath Panneerselvam's avatar

Ha..hmm..

Expand full comment
Nishant Ajugia's avatar

Thank you sir for keep it open

Expand full comment
Sajal Kapoor's avatar

YouTube is all open my friend. Will do a free session there with Prince next month.

Expand full comment
Rahul Bhardwaj's avatar

When you get an opportunity please share on how you see Max India as a long term opportunity or not on the India aging population and healthcare needs and your views on the management and business. They recently released their results.

Expand full comment
Sajal Kapoor's avatar

Max India as I keep saying is a 10 year plus kind of opportunity but don't expect a positive PAT anytime soon. It's a unique business as Indian cross 55 and 60 in large volumes.

Expand full comment
AshishGupta's avatar

Sir could you please analyse Q3 results of Emcure pharma

Expand full comment
Sajal Kapoor's avatar

Noted. I will probably do a 60 seconds audio on all the 30 names.

Expand full comment
Saurabh Sharma's avatar

This is great analysis 🔥

Expand full comment
Saurabh Sharma's avatar

Tatva and Clean Science also.

Expand full comment
Sajal Kapoor's avatar

I will probably do a 60 seconds audio on all the 30 names. The framework is same but then every chemical, CDMO business is so unique that we can never call these pockets as sectors like some of the other. Randomness and volatility will always harm the fragile and we have to learn to live in this random world. Lumpiness and randomness will only increase in future :)

Expand full comment
Ashok Kumar's avatar

Sir, would love your comments on Tatva Chintan results. The management seemed upbeat this time.

Expand full comment
Sajal Kapoor's avatar

Not have had the time for deeper dive, but Tatva Chintan's gross margins never collapsed, even in tough times and that's a good sign. See my template is heavy on randomness and promoter/management quality (99% of terminal value is always there in my view).

Expand full comment
vikram's avatar

Missed the note on reducing exposure to Bliss. Can someone share that post link again. Thanks!

Expand full comment
vikram's avatar

Great agility sir, looking to learn slowly. Missed the post on X, as I started following only on Substack now.

While BlissGVS is not at Point A currently, I got confidence it's still a great asset to own for 3-5 year horizon. Hope the thesis remained intact from your analysis as well. Thanks 👍

Expand full comment
MEHUL SHAH's avatar

Thanks a lot sir... 👍

Expand full comment
brammanand's avatar

Sir you tweeted about about couple of chemical stories near Point A, which one are these and are you making a presentation this sir. thanks

Expand full comment
Sajal Kapoor's avatar

It's a cyclical industry, so some stocks will go from point A to point B in 1 year, and others will take 5-7 years; GMP chemicals are difficult to master and make; non-GMP are easier; The level of randomness in the industry is extremely high, so it's advisable to invest in only one or two stocks and avoid placing large bets if you haven't read the annual reports and transcripts of the previous years (5 years plus). Failure to do so can lead to big accidents. I keep sharing names in my presentations to help embed the framework.

Expand full comment
Harshil's avatar

Sir I still want to know what do you mean when you said Laurus will surprise the bulls. You said it will be covered in part 2A/B. If you can address it in numbers. What mcap are you expecting?

Expand full comment
Sajal Kapoor's avatar

Expectations - Actual = Happiness. Aim low :)

Expand full comment
Harsh's avatar

Hello sir, would love a 60 seconds view on Deepak Nitrite's Q3. Margins have taken a hit. Even if you do it after their earnings call, it's well appreciated as you're anyway giving us so much of your time. Thanks!

Expand full comment
Sajal Kapoor's avatar

Weak numbers (weaker than expected, but that's randomness). Read my FY25 outlook here - https://antifragilethinking.substack.com/p/3q-fy25-kopran-and-deepak-nitrite

Expand full comment
Saravanan Subramani's avatar

Sir Syngene's PE still above 50, what's your thought? Thank you🙏

Expand full comment
Sajal Kapoor's avatar

Avoid what you don't understand; Valuation masterclasses will take another 8-10 months to complete; there's is no short cut and I will never recommend stock specific trades on this channel please.

Expand full comment
Hardik Patel's avatar

Can anybody help me with subscription

Expand full comment
Krunal Patel's avatar

Hi Sir,

How do you look at Bodal Chemicals ?

Results are not that great but they are expanding into Benzene derivatives so do you think future will be good from here ?

They have closed some of the non performing businesses.

Valuation wise looks cheap also.

Expand full comment